We are a purpose-driven company
Our mission is to dramatically improve the management of cancer patients by providing simple and non-invasive tools, to assist oncologists in making the best informed decisions for each patient.
We are a deeptech start-up
Oncosema operates an exclusive technology targeting cancer-specific biomarkers, allowing the quantification and the isolation of Circulating Tumor Cells (CTC) from most types of cancer.
WHY can CTC and blood testing help monitoring cancer?
HOW is Oncosema technology innovative ?
We are focused on
providing impactful tests for Oncology
Non-invasive
Implemented within a simple blood draw.
Sensitive and Specific
Unprecedented purity and cell viability
Easy-to-use
Providing reliable information on cancer evolution in less than 90'